Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2008Anti-Cancer Drugs

Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine

View Full Paper
Ask AI
Bookmark
Share

Authors

YFYoshiro FujiwaraTsuyama Chuo HospitalKKKatsuyuki KiuraOkayama University HospitalMTMasahiro TabataOkayama University Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fujiwara et al. (2008) studied this question.

synapsesocial.com/papers/6a8d86110b453ccb7788e52bhttps://doi.org/10.1097/cad.0b013e3282f5d336
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma2007 · 4,815 citations
  2. 2Cavitary Pulmonary Metastases1965 · 31 citations
  3. 3Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma2007 · 5,803 citations
  4. 4Use of Antibodies to RCC and CD10 in the Differential Diagnosis of Renal Neoplasms2000 · 367 citations